Friday 6 November 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Revenue
- +23.1%
- EPS
- +82.2%
- Free cash flow
- +95.7%
- Total debt
- +8.44%
Quarter to September 2026, against a year earlier
75.66
5.23
+7.43%
Follow TEM
Alert me
Tempus AI, Inc. (TEM) SEC filings, changes and red flags
Red flags
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Sep 30, 2026 |
P1I2: 5 added · 3 removed · 46 modified P2I1A: no changes |
||
| 8-K | Nov 2, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Oct 23, 2026 | 8.01 Other events | ||
| 10-Q | Jun 30, 2026 |
P1I2: 35 added · 5 removed · 62 modified P2I1A: 42 added · 1 modified |
||
| 8-K | Jul 30, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Jul 20, 2026 | 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits | ||
| 8-K | Jul 20, 2026 | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | May 21, 2026 | 5.07 Submission of matters to a vote of security holders | ||
| 8-K | May 7, 2026 | 1.01 Entry into a material definitive agreement; 1.02 Termination of a material definitive agreement; 2.03 Creation of a direct financial obligation; 3.02 Unregistered sales of equity securities; 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2026 | |||
| 8-K | May 5, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2025 |
1: 23 added · 12 removed · 110 modified 1A: 38 added · 31 removed · 200 modified 7: 48 added · 34 removed · 50 modified |
||
| 8-K | Feb 24, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 11, 2026 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2025 | |||
| 8-K | Nov 4, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Aug 27, 2025 | 8.01 Other events; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2025 | |||
| 8-K | Aug 8, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Mar 31, 2025 | |||
| 8-K | May 6, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-K | Dec 31, 2024 | |||
| 8-K | Feb 24, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 8-K | Jan 13, 2025 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2024 | |||
| 8-K | Nov 4, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Aug 6, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits |